Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
4.490
+0.200 (4.66%)
At close: Jun 5, 2026, 4:00 PM EDT
4.390
-0.100 (-2.23%)
After-hours: Jun 5, 2026, 7:43 PM EDT
Quoin Pharmaceuticals Employees
As of December 31, 2025, Quoin Pharmaceuticals had 6 total employees, including 4 full-time and 2 part-time employees. The number of employees increased by 1 or 20.00% compared to the previous year.
Employees
6
Change (1Y)
1
Growth (1Y)
20.00%
Revenue / Employee
n/a
Profits / Employee
-$2,831,702
Market Cap
8.10M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 6 | 1 | 20.00% | 4 | 2 |
| Dec 31, 2024 | 5 | 1 | 25.00% | 3 | 2 |
| Dec 31, 2023 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2022 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2021 | 4 | 2 | 100.00% | 4 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| PMGC Holdings | 34 |
| Imunon | 20 |
| Genprex | 13 |
| Processa Pharmaceuticals | 12 |
| NuCana | 12 |
| CNS Pharmaceuticals | 8 |
| Enveric Biosciences | 6 |
| Creative Medical Technology Holdings | 4 |
QNRX News
- 1 day ago - Quoin Pharmaceuticals granted Orphan Drug Designation for QRX003 in Japan - TheFly
- 1 day ago - Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome - GlobeNewsWire
- 3 days ago - Quoin Pharmaceuticals submits QRX003 IND application to FDA - TheFly
- 3 days ago - Quoin Pharmaceuticals Submits IND Application for QRX003 in Peeling Skin Syndrome - GlobeNewsWire
- 4 weeks ago - Quoin Pharmaceuticals Earnings release: Q1 2026 - Filings
- 4 weeks ago - Quoin Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Quoin Pharmaceuticals Provides Corporate Update and Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 4 weeks ago - Quoin Pharmaceuticals initiated with a Buy at Lucid Capital - TheFly